Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
American experts have advise doctors to screen all patients between the ages of 19 and 65 for anxiety disorders
- By Newsdesk
- U.S.A
- Jun 23, 2023
In a historic development, a prominent group of experts in preventive health from the United States has recommended that doctors conduct anxiety disorder screenings for all patients aged 19 to 65. The U.S. Preventive Services Task Force (USPSTF), whose recommendations were published in the Journal of the American Medical Association, states that current data indicate the benefits of anxiety screenings in providing peace of mind for these patients. Dr. Michael Silverstein, Vice President of the USPSTF, explains that the evidence strongly supports a reduction in anxiety symptoms and an improvement in overall quality of life among adults aged 19 to 64. The task force also emphasizes the ongoing recommendation for regular depression screenings in adults.
While acknowledging that suicide is a leading cause of death among adults, the experts do not currently endorse routine screening for suicide risk. The significance of mental health for Americans has been underscored by the pandemic, as stated by Dr. Petros Levunis, President of the American Psychiatric Association (APA).
According to the World Health Organization's 2022 Scientific Summary, there was a 25 percent global increase in the prevalence of anxiety and depression during the first year of the pandemic. Furthermore, a May poll conducted by the APA revealed that 37 percent of Americans reported feeling more anxious this year compared to the previous year, marking a 5 percent increase.